Antimicrobial Susceptibility Patterns of Mycobacteriumtuberculosis Complex Isolates in the Dominican Republic (2021–2025): A Retrospective Study from a Private Referral Laboratory

Drug-resistant tuberculosis (TB) is a major global health challenge. This retrospective, laboratory-based study aimed to describe the antimicrobial susceptibility profile of Mycobacterium tuberculosis complex isolates in the Dominican Republic and to assess factors associated with antimicrobial resistance. All culture-confirmed clinical M. tuberculosis complex isolates processed in a private referral microbiology laboratory from 2021 to 2025 were included. Drug susceptibility testing was performed according to CLSI M62 recommendations. A total of 184 patients were included. Median age was 38 years (interquartile range 28–50), and 70.7% of isolates were obtained from pulmonary specimens. Overall, 136 isolates (73.9%) were susceptible to all tested drugs, whereas 48 (26.1%) were resistant to at least one drug. The most frequent resistance was to isoniazid (n = 29; 15.8%) and streptomycin (n = 27; 14.7%), followed by rifampicin (n = 11; 6.0%). Pyrazinamide resistance was uncommon (n = 4; 2.2%), and no resistance was detected to ethambutol, second-line injectable agents, or fluoroquinolones. Among the 11 rifampicin-resistant isolates, three (1.6% of all isolates) were rifampicin-resistant without concomitant isoniazid resistance, whereas eight (4.3%) were multidrug-resistant (MDR-TB). In conclusion, more than one-quarter of isolates were resistant to at least one anti-TB drug, most commonly isoniazid and streptomycin. Overall rifampicin resistance, including MDR-TB, was detected in 6.0% of isolates. These findings highlight the need to strengthen drug resistance surveillance and expand access to rapid molecular and phenotypic drug susceptibility testing to guide appropriate treatment and support TB control strategies in the Dominican Republic.

Authors

Institutions

Publication Details

Journal
Tropical Medicine and Infectious Disease
Published
2026-11-16
DOI
https://doi.org/10.3390/tropicalmed11110326
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antimicrobial Susceptibility Patterns of Mycobacteriumtuberculosis Complex Isolates in the Dominican Republic (2021–2025): A Retrospective Study from a Private Referral Laboratory

Clevy Perez, José Manuel Ramos, Joana Bacalhau, Ysabel-Noemi Tejeda-Diaz et al.
2 links
Tropical Medicine and Infectious Disease
Tuberculosis Research and Epidemiology
article

Antimicrobial Susceptibility Patterns of Mycobacteriumtuberculosis Complex Isolates in the Dominican Republic (2021–2025): A Retrospective Study from a Private Referral Laboratory

Clevy Perez, José Manuel Ramos, Joana Bacalhau, Ysabel-Noemi Tejeda-Diaz, Yicenia-Aralisis Brito-Beltre, Esther Rodríguez-Marte
article en

Abstract

Drug-resistant tuberculosis (TB) is a major global health challenge. This retrospective, laboratory-based study aimed to describe the antimicrobial susceptibility profile of Mycobacterium tuberculosis complex isolates in the Dominican Republic and to assess factors associated with antimicrobial resistance. All culture-confirmed clinical M. tuberculosis complex isolates processed in a private referral microbiology laboratory from 2021 to 2025 were included. Drug susceptibility testing was performed according to CLSI M62 recommendations. A total of 184 patients were included. Median age was 38 years (interquartile range 28–50), and 70.7% of isolates were obtained from pulmonary specimens. Overall, 136 isolates (73.9%) were susceptible to all tested drugs, whereas 48 (26.1%) were resistant to at least one drug. The most frequent resistance was to isoniazid (n = 29; 15.8%) and streptomycin (n = 27; 14.7%), followed by rifampicin (n = 11; 6.0%). Pyrazinamide resistance was uncommon (n = 4; 2.2%), and no resistance was detected to ethambutol, second-line injectable agents, or fluoroquinolones. Among the 11 rifampicin-resistant isolates, three (1.6% of all isolates) were rifampicin-resistant without concomitant isoniazid resistance, whereas eight (4.3%) were multidrug-resistant (MDR-TB). In conclusion, more than one-quarter of isolates were resistant to at least one anti-TB drug, most commonly isoniazid and streptomycin. Overall rifampicin resistance, including MDR-TB, was detected in 6.0% of isolates. These findings highlight the need to strengthen drug resistance surveillance and expand access to rapid molecular and phenotypic drug susceptibility testing to guide appropriate treatment and support TB control strategies in the Dominican Republic.

Tropical Medicine and Infectious DiseaseVol. 11(11)
Universitat de Miguel Hernández d'Elx (ES), Universidad Autónoma de Santo Domingo (DO), Hospital General Universitario de Alicante Doctor Balmis (ES), Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL) (ES)
Good health and well-being
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon